Skip to main content
Retour
ZTS logo

Zoetis Inc.

Qualité des données : 100%
ZTS
NYSE Healthcare Drug Manufacturers - Specialty & Generic
116,71 €
▲ 0,78 € (0,67%)
Cap. Boursière : 51,43B
Fourchette du Jour
115,30 € 118,14 €
Fourchette 52 Semaines
114,36 € 172,23 €
Volume
3 078 490
Moyenne 50J / 200J
124,41 € / 138,35 €
Clôture Précédente
115,93 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E 19,2 0,2
P/B 15,4 3,0
ROE % 66,0 3,6
Net Margin % 28,2 3,8
Rev Growth 5Y % 5,0 9,9
D/E 2,9 0,2

Objectif de Cours des Analystes

Hold
143,86 € +23.3%
Low: 135,00 € High: 160,00 €
P/E Prévisionnel
16,65
BPA Prévisionnel
7,01 €
Croissance BPA (est.)
+0,0%
CA Est.
9,91B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 9,27 €
9,10 € – 9,46 €
11,86B 1
FY2029 8,69 €
8,54 € – 8,88 €
11,35B 1
FY2028 8,16 €
7,75 € – 8,40 €
10,91B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 1,40 € 1,48 € +5,7%
2025-11-04 1,62 € 1,70 € +4,9%
2025-08-05 1,62 € 1,76 € +8,6%
2025-05-06 1,41 € 1,48 € +5,0%
2025-02-13 1,37 € 1,40 € +2,2%
2024-11-04 1,46 € 1,58 € +8,2%
2024-08-06 1,49 € 1,56 € +4,7%
2024-05-02 1,34 € 1,38 € +3,0%

Dividend History

7 yr streak

Yield

0,02%

Payout Ratio

0,33%

Growth (3Y)

15,44%

Growth (5Y)

20,11%

Ex-Date Payment Date Amount Yield
Apr 20, 2026 Jun 02, 2026 0,53 € 1,77%
Jan 20, 2026 Mar 03, 2026 0,53 € 1,65%
Oct 31, 2025 Dec 02, 2025 0,50 € 1,39%
Jul 18, 2025 Sep 03, 2025 0,50 € 1,30%
Apr 21, 2025 Jun 03, 2025 0,50 € 1,27%
Jan 21, 2025 Mar 04, 2025 0,50 € 1,07%
Oct 31, 2024 Dec 03, 2024 0,43 € 0,97%
Jul 18, 2024 Sep 04, 2024 0,43 € 0,93%
Apr 18, 2024 Jun 04, 2024 0,43 € 1,05%
Jan 18, 2024 Mar 01, 2024 0,43 € 0,82%
Oct 31, 2023 Dec 01, 2023 0,38 € 0,96%
Jul 20, 2023 Sep 01, 2023 0,38 € 0,84%
Apr 20, 2023 Jun 01, 2023 0,38 € 0,80%
Jan 19, 2023 Mar 01, 2023 0,38 € 0,83%
Oct 31, 2022 Dec 01, 2022 0,33 € 0,86%
Jul 20, 2022 Sep 01, 2022 0,33 € 0,70%
Apr 20, 2022 Jun 01, 2022 0,33 € 0,61%
Jan 19, 2022 Mar 01, 2022 0,33 € 0,54%
Oct 28, 2021 Dec 01, 2021 0,25 € 0,47%
Jul 20, 2021 Sep 01, 2021 0,25 € 0,47%

Points Clés

Revenue grew 5,04% annually over 5 years — modest growth
ROE of 65,99% indicates high profitability
Net margin of 28,23% shows strong profitability
Debt/Equity of 2,85 — high leverage
Generating 2,28B in free cash flow
Cash machine — converts 85,41% of earnings into free cash flow

Croissance

Revenue Growth (5Y)
5,04%
Revenue (1Y)2,28%
Earnings (1Y)7,52%
FCF Growth (3Y)18,68%

Qualité

Return on Equity
65,99%
ROIC21,04%
Net Margin28,23%
Op. Margin38,00%

Sécurité

Debt / Equity
2,85
Current Ratio3,03
Interest Coverage14,80

Valorisation

P/E Ratio
19,24
Forward P/E16,65
P/B Ratio15,44
EV/EBITDA16,30
Dividend Yield0,02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2,28% Revenue Growth (3Y) 5,26%
Earnings Growth (1Y) 7,52% Earnings Growth (3Y) 6,79%
Revenue Growth (5Y) 5,04% Earnings Growth (5Y) 7,03%
Profitability
Revenue (TTM) 9,47B Net Income (TTM) 2,67B
ROE 65,99% ROA 17,28%
Gross Margin 70,49% Operating Margin 38,00%
Net Margin 28,23% Free Cash Flow (TTM) 2,28B
ROIC 21,04% FCF Growth (3Y) 18,68%
Safety
Debt / Equity 2,85 Current Ratio 3,03
Interest Coverage 14,80
Dividends
Dividend Yield 0,02% Payout Ratio 0,33%
Dividend Growth (3Y) 15,44% Dividend Growth (5Y) 20,11%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 19,24 Forward P/E 16,65
P/B Ratio 15,44 P/S Ratio 5,43
PEG Ratio 2,04 Forward PEG N/A
EV/EBITDA 16,30 Fwd EV/EBITDA 13,08
Forward P/S 5,19 Fwd Earnings Yield 6,01%
FCF Yield 4,44%
Market Cap 51,43B Enterprise Value 58,61B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9,47B 9,26B 8,54B 8,08B 7,78B
Net Income 2,67B 2,49B 2,34B 2,11B 2,04B
EPS (Diluted) 6,02 5,47 5,07 4,49 4,27
Gross Profit 6,67B 6,40B 5,83B 5,48B 5,31B
Operating Income 3,60B 3,39B 3,07B 2,93B 2,80B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15,47B 14,24B 14,29B 14,93B 13,90B
Total Liabilities 12,14B 9,47B 9,30B 10,52B 9,36B
Shareholders' Equity 3,33B 4,77B 5,00B 4,41B 4,54B
Total Debt 9,49B 6,74B 6,76B 8,09B 6,74B
Cash & Equivalents 2,31B 1,99B 2,04B 3,58B 3,48B
Current Assets 6,77B 5,99B 6,34B 7,51B 6,93B
Current Liabilities 2,24B 3,41B 1,89B 3,17B 1,80B